Zinc supplements for stable advanced liver disease
Part of Cancer, Digestive system clinical trials.
This trial tests whether taking zinc supplements can improve the outlook for people with a certain type of advanced liver disease that is still stable (no major complications). If you have compensated advanced chronic liver disease and meet the criteria, you might be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You must have been diagnosed with compensated advanced chronic liver disease (cACLD) and a liver stiffness test (FibroScan) showing a value greater than 15 kPa.
- You must have never had a liver decompensation event (like fluid buildup in the belly, bleeding from the esophagus, or confusion).
- You must not have liver cancer (hepatocellular carcinoma) now or in the past.
- You must not have another serious illness that could shorten your life in the near future.
- If you are a woman who could become pregnant, you must agree to use effective birth control and have a negative pregnancy test before starting. Men also must use contraception.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests different doses of zinc supplements combined with standard targeted therapy and immunotherapy for advanced liver cancer.
This trial tests a combination of two drugs, zanzalintinib and durvalumab, as a maintenance treatment for people with advanced liver cancer (hepatocellular cancer) that has not gotten worse after initial treatment with tremelimumab and durvalumab. The goal is to see if this combination can help keep the cancer from growing.
This trial tests whether taking zinc supplements helps HIV patients who have low CD4 cell counts even when their virus is well-controlled. If your zinc levels are normal but your immune cells are slow to recover, this might be for you.
This study tests whether taking zinc sulfate can help reduce liver scarring in people with chronic hepatitis B who are already on antiviral medication. If you have moderate liver scarring, you may join to see if zinc improves your liver health.
This trial tests whether taking copper supplements can help people with cirrhosis (scarring of the liver) who have low copper levels or symptoms related to copper deficiency. It aims to see if this can improve their health.
This study tests whether a new drug called AZD2389 is safe and well-tolerated in adults with steatotic liver disease (fatty liver) that has progressed to advanced scarring. The trial aims to see if this drug might help slow or improve liver damage in people with this condition.
Hear when a new Advanced Chronic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.